332 related articles for article (PubMed ID: 20096751)
1. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
Zhao C; Li M
Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
[TBL] [Abstract][Full Text] [Related]
2. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
Zhao C; Li M
Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
[TBL] [Abstract][Full Text] [Related]
3. 5-HT
Gao J; Chen L; Li M
Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
[TBL] [Abstract][Full Text] [Related]
4. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
5. Blockade of serotonin 5-HT
Nie L; Di T; Li Y; Cheng P; Li M; Gao J
Pharmacol Biochem Behav; 2018 Aug; 171():74-84. PubMed ID: 29944910
[TBL] [Abstract][Full Text] [Related]
6. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
[TBL] [Abstract][Full Text] [Related]
7. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.
Tremblay PO; Gervais J; Rouillard C
Eur J Neurosci; 1998 Nov; 10(11):3546-55. PubMed ID: 9824467
[TBL] [Abstract][Full Text] [Related]
8. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
Deutch AY; Duman RS
Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
[TBL] [Abstract][Full Text] [Related]
9. Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.
Feng M; Gao J; Sui N; Li M
Psychopharmacology (Berl); 2015 Apr; 232(7):1219-30. PubMed ID: 25288514
[TBL] [Abstract][Full Text] [Related]
10. 2-Bromoterguride-a potential atypical antipsychotic drug without metabolic effects in rats.
Franke RT; Tarland E; Fink H; Pertz HH; Brosda J
Psychopharmacology (Berl); 2016 Aug; 233(15-16):3041-50. PubMed ID: 27317020
[TBL] [Abstract][Full Text] [Related]
11. Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions.
Sebens JB; Kuipers SD; Koch T; Ter Horst GJ; Korf J
Eur J Pharmacol; 2000 Nov; 408(1):11-7. PubMed ID: 11070178
[TBL] [Abstract][Full Text] [Related]
12. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
Werme M; Ringholm A; Olson L; Brené S
Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
[TBL] [Abstract][Full Text] [Related]
13. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
15. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
Fujimura M; Hashimoto K; Yamagami K
Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.
Collins CM; Wood MD; Elliott JM
J Psychopharmacol; 2014 Oct; 28(10):947-54. PubMed ID: 24989643
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
[TBL] [Abstract][Full Text] [Related]
18. Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.
Zhao C; Li M
Pharmacol Biochem Behav; 2009 Mar; 92(1):147-56. PubMed ID: 19041338
[TBL] [Abstract][Full Text] [Related]
19. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
[TBL] [Abstract][Full Text] [Related]
20. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
